Archived Facts

Posts Tagged ‘Puma’

Pfizer said Wednesday it entered a licensing agreement with Puma Biotechnology for the development and marketing of neratinib, an experimental drug that has shown promise in treating a subset of breast cancer patients.

Related Posts: